At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
HIMS Hims & Hers Health Inc.
Market Closed 07-10 16:00:00 EDT
34.38
-1.07
-3.02%
盘后34.21
-0.17-0.49%
19:59 EDT
High36.46Low33.18Vol11.85M
Open35.84D1 Closing35.45Amplitude9.25%
Mkt Cap7.94BTradable Cap7.24BTotal Shares231.07M
T/O405.26MT/O Rate5.63%Tradable Shares210.59M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Movement Alert｜Hims & Hers Health Falls 5.36% in Regular Trading, Insider Selling Filings Add to Ongoing Fundamental Pressure
Market Focus  ·  07-10 22:25
Movement Alert｜Hims & Hers Health Falls 5.36% in Regular Trading, Insider Selling Filings Add to Ongoing Fundamental Pressure
Hims & Hers's Peptide Opportunity Remains in Focus
Dow Jones  ·  07-10
Hims & Hers's Peptide Opportunity Remains in Focus
Hims & Hers Health is Maintained at Neutral by B of a Securities
Dow Jones  ·  07-09
Hims & Hers Health is Maintained at Neutral by B of a Securities
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Tarsus Pharmaceuticals (TARS)
TIPRANKS  ·  07-09
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Tarsus Pharmaceuticals (TARS)
Movement Alert｜Hims & Hers Health Falls 5.11% in Regular Trading, Trading at $34.26
Market Focus  ·  07-08
Movement Alert｜Hims & Hers Health Falls 5.11% in Regular Trading, Trading at $34.26
Movement Alert｜Hims & Hers Health Falls 5.2% in Pre-Market Trading, Trading at $34.45
Market Focus  ·  07-08
Movement Alert｜Hims & Hers Health Falls 5.2% in Pre-Market Trading, Trading at $34.45
Hims & Hers CFO Oluyemi Okupe Disposes of 7,163 Common Shares for $261,540.56
Reuters  ·  07-08
Hims & Hers CFO Oluyemi Okupe Disposes of 7,163 Common Shares for $261,540.56
Movement Alert｜Hims & Hers Health Declines 5.02% in Regular Trading, Trading at $36.33
Market Focus  ·  07-08
Movement Alert｜Hims & Hers Health Declines 5.02% in Regular Trading, Trading at $36.33
Movement Alert｜Hims & Hers Health Rises 5.14% in Regular Trading, Continued Momentum Following BofA Price Target Upgrade
Market Focus  ·  07-06
Movement Alert｜Hims & Hers Health Rises 5.14% in Regular Trading, Continued Momentum Following BofA Price Target Upgrade
Trump's FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In?
Dow Jones  ·  07-05
Trump's FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In?
Hims & Hers Health (HIMS) Secures $400 Million Financing, Is The Upside Already Priced In?
Simply Wall St.  ·  07-02
Hims & Hers Health (HIMS) Secures $400 Million Financing, Is The Upside Already Priced In?
Hims & Hers Health - Receivables Purchase Agreement Has Initial 364-day Term, Extendable by Written Agreement - SEC Filing
THOMSON REUTERS  ·  07-02
Hims & Hers Health - Receivables Purchase Agreement Has Initial 364-day Term, Extendable by Written Agreement - SEC Filing
Hims & Hers Signs USD 400 Million Receivables Purchase Facility with Jpmorgan Chase
Reuters  ·  07-02
Hims & Hers Signs USD 400 Million Receivables Purchase Facility with Jpmorgan Chase
Sector Update: Healthcare
MT Newswires Live  ·  07-02
Sector Update: Healthcare
Movement Alert｜Hims & Hers Health Rises 5.12% in Regular Trading, BofA Securities Raises Price Target to $36 From $25
Market Focus  ·  07-01
Movement Alert｜Hims & Hers Health Rises 5.12% in Regular Trading, BofA Securities Raises Price Target to $36 From $25
BofA Securities Adjusts Hims & Hers Health Price Target to $36 From $25, Maintains Neutral Rating
MT Newswires Live  ·  07-01
BofA Securities Adjusts Hims & Hers Health Price Target to $36 From $25, Maintains Neutral Rating
Hims & Hers Health is Maintained at Neutral by B of a Securities
Dow Jones  ·  07-01
Hims & Hers Health is Maintained at Neutral by B of a Securities
HIMS Stock Jumps after Canaccord Raises Price Target to Street-High of $40
TIPRANKS  ·  07-01
HIMS Stock Jumps after Canaccord Raises Price Target to Street-High of $40
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Oruka Therapeutics (ORKA) and Hims & Hers Health (HIMS)
TIPRANKS  ·  07-01
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Oruka Therapeutics (ORKA) and Hims & Hers Health (HIMS)
Hims & Hers : Bofa Global Research Raises Price Objective to $36.00 from $25.00
THOMSON REUTERS  ·  07-01
Hims & Hers : Bofa Global Research Raises Price Objective to $36.00 from $25.00

Introduction

Company Name.
Hims & Hers Health Inc.
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Issue price:
--